SIGNIFICANCE OF THE T(1418) TRANSLOCATION AND BCL-2 GENE DEREGULATION IN NON-HODGKINS-LYMPHOMA

被引：0
|
作者：
MCDONNELL, TJ
机构：
来源：
DIAGNOSTIC ONCOLOGY | 1994年 / 4卷 / 01期
关键词：
BCL-2; ONCOGENE; APOPTOSIS; LYMPHOMA; CHROMOSOMAL TRANSLOCATION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The bcl-2 proto-oncogene was discovered by cloning the t(14;18)(q32;q21) translocation breakpoint seen in most follicular lymphomas. However, bcl-2 may be highly expressed in the absence of the t(14;18) so that assessment of its prognostic significance must be based on gene expression as well as cytogenetics. The bcl-2 oncogene is unique in its ability to extend cellular viability by overriding programmed cell death without augmenting cellular proliferation. Therapeutic interventions are now being implemented to induce programmed cell death in lymphoid malignancies.
引用
收藏
页码：18 / 21
页数：4
相关论文
共 50 条
  • [31] Clinical significance of BCL-2 in aggressive non-Hodgkin lymphoma
    Genadieva-Stavrik, S
    Cevreska, L
    Stojanoski, Z
    Pivkova, A
    Trajkova, S
    Ivkovski, L
    Zografski, G
    ANNALS OF ONCOLOGY, 2005, 16 : 173 - 173
  • [32] NON-HODGKINS-LYMPHOMA WITH PRIMARY SPLENOMEGALY (2 CASES)
    MISHKOVA, RG
    DIMITROV, DG
    KUDEVA, KV
    ZAKHARIEV, AK
    BRYCHKOVA, YS
    VOPROSY ONKOLOGII, 1990, 36 (07) : 879 - 880
  • [33] THE ROLE OF THE BCL-2 GENE IN LYMPHOMA
    COTTER, FE
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (04) : 449 - 453
  • [34] FOLLICULAR CENTER CELL LYMPHOMA WITH THE T(14 18) TRANSLOCATION IN WHICH THE REARRANGED BCL-2 GENE IS SILENT
    WANG, J
    RAFFELD, M
    MEDEIROS, LJ
    LONGO, DL
    JAFFE, ES
    DUFFEY, P
    STETLERSTEVENSON, M
    LEUKEMIA, 1993, 7 (11) : 1834 - 1839
  • [35] CLINICAL-SIGNIFICANCE OF BCL-2-MBR GENE REARRANGEMENT AND PROTEIN EXPRESSION IN DIFFUSE LARGE-CELL NON-HODGKINS-LYMPHOMA - AN ANALYSIS OF 83 CASES
    TANG, SC
    VISSER, L
    HEPPERLE, B
    HANSON, J
    POPPEMA, S
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 149 - 154
  • [36] IMMUNOHISTOCHEMICAL DETECTION OF P53-PROTEINS AND BCL-2-PROTEINS IN NON-HODGKINS-LYMPHOMA
    PEZZELLA, F
    MORRISON, H
    JONES, M
    GATTER, KC
    LANE, D
    HARRIS, AL
    MASON, DY
    HISTOPATHOLOGY, 1993, 22 (01) : 39 - 44
  • [37] BONE MARROWS OF NON-HODGKINS-LYMPHOMA PATIENTS WITH A BCL-2 TRANSLOCATION CAN BE PURGED OF POLYMERASE CHAIN REACTION-DETECTABLE LYMPHOMA-CELLS USING MONOCLONAL-ANTIBODIES AND IMMUNOMAGNETIC BEAD DEPLETION
    GRIBBEN, JG
    SAPORITO, L
    BARBER, M
    BLAKE, KW
    EDWARDS, RM
    GRIFFIN, JD
    FREEDMAN, AS
    NADLER, LM
    BLOOD, 1992, 80 (04) : 1083 - 1089
  • [38] Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation
    Schraders, M
    de Jong, D
    Kluin, P
    Groenen, PC
    van Krieken, H
    JOURNAL OF PATHOLOGY, 2005, 205 (03): : 329 - 335
  • [39] IMPAIRED PRODUCTION OF INTERLEUKIN-2 IN PATIENTS WITH HODGKINS AND NON-HODGKINS-LYMPHOMA
    MUSATTI, CC
    YASAKA, K
    MENDES, NF
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1985, 18 (5-6) : A621 - A621
  • [40] EXPRESSION OF THE BCL-2 GENE IN HODGKINS-DISEASE
    THOMPSON, IW
    COATES, PJ
    NORTON, AJ
    JOURNAL OF PATHOLOGY, 1991, 164 (04): : A348 - A348
12345